Phase I/II study of 19-nor-1α-25-dihydroxyvitamin D2 (paricalcitol) in advanced, androgen-insensitive prostate cancer

Gary G. Schwartz, M. Craig Hall, Diana Stindt, Suzanne Patton, James Lovato, Frank M. Torti

Research output: Contribution to journalArticlepeer-review

76 Scopus citations

Fingerprint Dive into the research topics of 'Phase I/II study of 19-nor-1α-25-dihydroxyvitamin D<sub>2</sub> (paricalcitol) in advanced, androgen-insensitive prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences